Most Farxiga Diabetic Ketoacidosis Claims Dismissed In Federal Case

Mealey's (February 27, 2017, 3:17 PM EST) -- GREENVILLE, Miss. — A Mississippi federal judge on Feb. 22 dismissed without prejudice most of a plaintiff’s Farxiga diabetic ketoacidosis (DKA) claims (Kamilah Young v. Bristol-Myers Squibb Company, et al., No....
To view the full article, register now.